Sun Pharma
| Personal information | |
|---|---|
| Full name | Sun Pharma |
| Company type | public |
| Founded | 1983 Mumbai, Maharashtra, India
|
Sun Pharmaceutical Industries Limitedis an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries.
History
[edit]Sun Pharmaceutical Industries Limited was founded in 1983 in Kolkata with a small portfolio of psychiatric medicines and a modest marketing team. The company initially focused on specialized therapeutic segments and gradually expanded through strategic acquisitions of pharmaceutical plants and brands across India and international markets. Listing on the stock exchange in 1994 provided access to capital and fueled rapid expansion.
Over the years, Sun Pharma pursued global growth by acquiring manufacturing facilities and specialty drug portfolios in the United States, Europe, and Asia. Major acquisitions, including dermatology and generic drug businesses, strengthened its international footprint. The 2014 acquisition of Ranbaxy Laboratories significantly expanded its scale, creating one of the world’s largest specialty generic pharmaceutical companies.
Today, Sun Pharma operates in more than 100 countries and manufactures a wide range of formulations and active pharmaceutical ingredients. Its global presence and investment in research and development support innovation in therapeutic areas such as dermatology, neurology, and oncology, positioning the company as a leader in the pharmaceutical industry.
Operations
[edit]Sun Pharmaceutical Industries Limited operates manufacturing facilities across 43 locations worldwide and supplies pharmaceutical products to international and domestic markets. The company focuses on diverse therapeutic areas and produces both branded and generic medicines, catering to global healthcare needs. Its distribution network and regulatory compliance enable market access in over 100 countries.
Business career
[edit]The business career of Sun Pharmaceutical Industries Limited reflects consistent growth through innovation and strategic acquisitions. Expansion into global markets and investment in specialty pharmaceuticals have strengthened its competitive position. The company continues to enhance its portfolio and market reach while prioritizing research and development to address evolving healthcare demands.
Ideology
[edit]The ideology of Sun Pharmaceutical Industries Limited emphasizes delivering affordable and high-quality pharmaceutical solutions. It prioritizes innovation, global healthcare accessibility, and ethical business practices. By focusing on patient-centric products and sustainable growth, the company aims to contribute meaningfully to healthcare advancements worldwide.
Social Links
[edit]References
- ^^ Jump up to: a b "Sun Pharma" "Sun Pharma reports Q4 and full year results for FY25"". Sun Pharma. Retrieved 2026-01-14.
- ^ Jump up to: a b "Sun Pharma" " "Statement of Audited Consolidated Financial Results for the Quarter and Year ended March 31, 2025"" . Retrieved 2026-01-10.
- ^ Jump up to: a b c "Sun Pharmaceuticals Industries Ltd". Business Standard India. Retrieved 2025-12-17.
- ^ BW Businessworld "Sun Pharma: Global Is Local". BW Businessworld. Retrieved 2025-12-17.
- ^ Jump up to: a b "US business remains Sun Pharma's weak spot". " www.fortuneindia.com" . 2025-12-09. ISSN 0971-8257. Retrieved 2025-12-17.
- ^ Jump up to: a b "MSN". www.msn.com. Retrieved 2025-12-17.